These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 30054)

  • 1. [Pharmacopsychiatry and iatrogenic parkinsonism].
    Pérez de Francisco C; Garnica Portillo R
    Neurol Neurocir Psiquiatr; 1978; 19(1):53-7. PubMed ID: 30054
    [No Abstract]   [Full Text] [Related]  

  • 2. Parkinson's disease.
    Barboi AC; Goetz CG
    Clin Neuropharmacol; 1999; 22(4):184-91. PubMed ID: 10442246
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of drug-induced psychosis in Parkinson's disease with ziprasidone can induce severe dose-dependent off-periods and pathological laughing.
    Schindehütte J; Trenkwalder C
    Clin Neurol Neurosurg; 2007 Feb; 109(2):188-91. PubMed ID: 16949733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selegiline for neuroleptic-induced parkinsonism.
    Gewirtz GR; Sharif Z; Cadet JL; Sarti P; Gorman JM
    Pharmacopsychiatry; 1993 Jul; 26(4):128-9. PubMed ID: 7901857
    [No Abstract]   [Full Text] [Related]  

  • 5. Neuroleptic-induced parkinsonism and Parkinson's disease: differential diagnosis and treatment.
    Hausner RS
    J Clin Psychiatry; 1983 Jan; 44(1):13-6. PubMed ID: 6130081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biperiden (Akineton): effective prophylactic and therapeutic anti-parkinsonian agent.
    Kline NS; Mason BT; Winick L
    Curr Ther Res Clin Exp; 1974 Aug; 16(8):838-43. PubMed ID: 4155670
    [No Abstract]   [Full Text] [Related]  

  • 7. [Value of clozapine in treatment of psychotic disorder in Parkinson disease].
    Abbar M; Courtet P; Castelnau D
    Encephale; 1996; 22(1):53-63. PubMed ID: 8681876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Complications of drug withdrawal from antiparkinson agents and neuroleptics].
    Mizon JP; Rosa A
    Therapie; 1984; 39(4):421-5. PubMed ID: 6148792
    [No Abstract]   [Full Text] [Related]  

  • 9. Parkinsonism--drug treatment: Part II.
    Berg MJ; Ebert B; Willis DK; Host T; Fincham RW; Schottelius DD
    Drug Intell Clin Pharm; 1987 Feb; 21(2):167-72. PubMed ID: 3549213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clozapine: new preparation. A last resort for parkinsonian patients with psychosis.
    Prescrire Int; 2002 Feb; 11(57):1-6. PubMed ID: 11985366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Future strategies for the treatment of Parkinson's disease.
    Fahn S
    Adv Neurol; 1993; 60():636-40. PubMed ID: 8420202
    [No Abstract]   [Full Text] [Related]  

  • 12. [Neuroleptic parkinsonism and tardive dyskinesia and methods of pharmacologically correcting these pathologic conditions (review)].
    Arushanian EB
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1985; 85(2):269-77. PubMed ID: 2858951
    [No Abstract]   [Full Text] [Related]  

  • 13. Anticholinergic equivalents and parkinsonism: a model for predicting side-effects of antipsychotic drugs.
    Menkes DB; Clarkson HO; Caradoc-Davies G; Mullen PE
    Int Clin Psychopharmacol; 1987 Jan; 2(1):55-67. PubMed ID: 2889760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clozapine withdrawal symptoms in a Parkinson's disease patient.
    Zesiewicz TA; Borra S; Hauser RA
    Mov Disord; 2002 Nov; 17(6):1365-7. PubMed ID: 12465085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [L-threo-DOPS therapy and parkinsonism].
    Narabayashi H
    No To Shinkei; 1986 Jan; 38(1):60-2. PubMed ID: 3083844
    [No Abstract]   [Full Text] [Related]  

  • 16. Portable device for quantifying parkinsonian wrist rigidity.
    Caligiuri MP
    Mov Disord; 1994 Jan; 9(1):57-63. PubMed ID: 7908119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risperidone versus clozapine in the treatment of psychosis in six patients with Parkinson's disease and other akinetic-rigid syndromes.
    Rich SS; Friedman JH; Ott BR
    J Clin Psychiatry; 1995 Dec; 56(12):556-9. PubMed ID: 8530331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pharmacopsychiatry and iatrogenic parkinsonism].
    Pérez de Francisco C; Garnica Portillo G
    Arch Neurobiol (Madr); 1978; 41(2):93-8. PubMed ID: 697518
    [No Abstract]   [Full Text] [Related]  

  • 19. [Parkinson syndrome: iatrogenic causes, iatrogenic treatment results].
    Burgunder JM
    Schweiz Med Wochenschr; 1996 Mar; 126(13):522-7. PubMed ID: 8658091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroleptic malignant syndrome precipitated by haloperidol following clozapine discontinuation.
    Mendhekar DN; Jiloha RC
    Aust N Z J Psychiatry; 2005 Oct; 39(10):947-8. PubMed ID: 16168023
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.